newsfilter
← Latest News
GlobeNewswire·

CERo Therapeutics, Inc. Announces Up to $8 Million Series D Financing

SOUTH SAN FRANCISCO, Calif, April 22, 2025 (GLOBE NEWSWIRE) -- CERo Therapeutics Holdings, Inc. (NASDAQ:CERO) ("CERo"), an innovative immunotherapy company seeking to advance the next generation of engineered T cell